Organon & Co Ordinary Shares OGN
News
Organon to Acquire Dermavant including its Innovative Dermatologic Therapy, VTAMA® (tapinarof) Cream, 1%
Organon to Acquire Dermavant including its Innovative Dermatologic Therapy, VTAMA® (tapinarof) Cream, 1%
Organon & Lilly Expand Migraine Commercialization Agreement to 11 Additional Markets
Organon Reports Results for the Second Quarter Ended June 30, 2024
Organon To Report Second Quarter 2024 Results and Host Conference Call on August 6, 2024
11 dividend stocks with high yields expected to be well supported in 2024 per strict criteria